We noted that when CA 19-9 was used for the diagnosis of the disease, pancreatic cancer was associated with higher DOR than CEA (DOR: 3.50; 95% CI: 2.24–5.45; P < 0.001; Figure 2(c)). This evidence concerns the gene CEACAM5 and pancreatic neoplasm.